Clay Wirestone writes about some of the new diabetes drugs over at DiabetesHealth. Check it out if interested in Symlin, Byetta, or Invokana. A snippet:
A lot of potential patients means that scientists are working on a lot of potential breakthroughs. But it’s hard to know, sometimes, which drugs are the real breakthroughs and which ones are simply hyped-up versions of already available treatments. Your team of medical professionals will help you. It pays to stay informed, as well, so you’re not surprised if a new treatment is suggested.
His writing isn’t as dry as my Drugs for Diabetes. But I cover all 12 available drug classes.
Diabetic Mediterranean Diet 